Nexomic is an Irish precision oncology TechBio company using artificial intelligence and multiomic data to improve how cancer is understood, studied, and treated.

The company develops advanced computational technologies that integrate complex molecular and clinical data to generate deeper insights into tumour biology, patient differences, treatment response, and disease progression.

Nexomic works across research, drug development, and clinical oncology, collaborating with pharmaceutical companies, healthcare institutions, research centres, and academic partners internationally.

Our mission is to make complex biological data more meaningful and actionable, supporting better research, more efficient drug development, and more personalised approaches to cancer care.

Why work with us

• Advanced expertise in AI, multiomics, computational biology, and precision oncology
• Ability to integrate complex molecular and clinical datasets into meaningful biological insights
• Applications spanning research, drug development, AI-biomarker discovery, clinical studies, and precision medicine
• Flexible collaboration models for pharmaceutical, healthcare, academic, and research organisations
• Strong focus on scientific validation and real-world clinical relevance
• International network of oncology, research, and healthcare collaborators
• Irish-based company with a global focus on advancing precision oncology

Nexomic combines AI, biology, and clinical science to help organisations derive greater value from complex cancer data and accelerate the translation of research into meaningful outcomes.